TOKYO and CAMBRIDGE, Mass., Jan 30, 2023 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that an application for manufacturing and marketing approval for lecanemab (generic name, U.S. brand name: LEQEMBI), an anti-amyloid-beta (Abeta) protofibril* antibody, in Japan has been designated for Priority Review by the Japanese Ministry of... » read more
TOKYO, Jul 6, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) under the accelerated approval pathway for lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild... » read more
SINGAPORE – The skills most urgently needed by Singaporeans have been identified in a new report by SkillsFuture Singapore (SSG). The inaugural Skills Demand For The Future Economy report was launched by Education Minister Chan Chun Sing on Wednesday (Dec 8). It pinpoints the top 20 clusters of skills in the digital, green and care sectors... » read more
SINGAPORE – A trial of MRT priority cabins for the elderly, wheelchair users and pregnant women has been put on hold indefinitely due to the coronavirus situation, The Sunday Times has learnt. A Land Transport Authority (LTA) spokesman told ST that ridership patterns have changed amid the Covid-19 outbreak and new initiatives will have to... » read more